Thomas M. Cunningham

Array ( [id] => 3619089 [patent_doc_number] => 05601828 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'CD8 derivatives and methods of use for cellular modulation and enhancement of cellular engraftment' [patent_app_type] => 1 [patent_app_number] => 8/112005 [patent_app_country] => US [patent_app_date] => 1993-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9542 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/601/05601828.pdf [firstpage_image] =>[orig_patent_app_number] => 112005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3412877 [patent_doc_number] => 05393523 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-02-28 [patent_title] => 'Plasmodium falciparum vaccine comprising a recombinant histidine-rich protein-HRP-II' [patent_app_type] => 1 [patent_app_number] => 8/109478 [patent_app_country] => US [patent_app_date] => 1993-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3426 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/393/05393523.pdf [firstpage_image] =>[orig_patent_app_number] => 109478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3644455 [patent_doc_number] => 05639458 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'Class I MHC modulation of surface receptor activity' [patent_app_type] => 1 [patent_app_number] => 8/105416 [patent_app_country] => US [patent_app_date] => 1993-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 24440 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639458.pdf [firstpage_image] =>[orig_patent_app_number] => 105416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3619711 [patent_doc_number] => 05612035 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-18 [patent_title] => 'Vaccination against diseases resulting from pathogenic responses by specific T cell populations' [patent_app_type] => 1 [patent_app_number] => 8/103418 [patent_app_country] => US [patent_app_date] => 1993-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3971 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/612/05612035.pdf [firstpage_image] =>[orig_patent_app_number] => 103418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3426115 [patent_doc_number] => 05403713 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-04-04 [patent_title] => 'Antibodies specific for ELAM-1 and the use thereof' [patent_app_type] => 1 [patent_app_number] => 8/102510 [patent_app_country] => US [patent_app_date] => 1993-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9260 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/403/05403713.pdf [firstpage_image] =>[orig_patent_app_number] => 102510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3421367 [patent_doc_number] => 05389530 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-02-14 [patent_title] => 'Methods for the production of antibodies and induction of immune responses to tumor-associated ganagliosides by immunization with gangloiside lactones' [patent_app_type] => 1 [patent_app_number] => 8/097006 [patent_app_country] => US [patent_app_date] => 1993-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7655 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/389/05389530.pdf [firstpage_image] =>[orig_patent_app_number] => 097006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3003404 [patent_doc_number] => 05374520 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-12-20 [patent_title] => 'Assay method for Epstein-Barr virus antibodies' [patent_app_type] => 1 [patent_app_number] => 8/091422 [patent_app_country] => US [patent_app_date] => 1993-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 6025 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/374/05374520.pdf [firstpage_image] =>[orig_patent_app_number] => 091422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3597599 [patent_doc_number] => 05559028 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-24 [patent_title] => 'Methods of enhancing or antigen presentation to T cells inhibiting' [patent_app_type] => 1 [patent_app_number] => 8/064400 [patent_app_country] => US [patent_app_date] => 1993-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13855 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/559/05559028.pdf [firstpage_image] =>[orig_patent_app_number] => 064400 [rel_patent_id] =>[rel_patent_doc_number] =>)